These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31808506)

  • 21. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population.
    Groenning BA; Raymond I; Hildebrandt PR; Nilsson JC; Baumann M; Pedersen F
    Heart; 2004 Mar; 90(3):297-303. PubMed ID: 14966052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incremental prognostic value of echocardiography in asymptomatic stage a heart failure.
    Carerj S; La Carrubba S; Antonini-Canterin F; Di Salvo G; Erlicher A; Liguori E; Monte I; Badano L; Pezzano A; Caso P; Pinto F; Di Bello V;
    J Am Soc Echocardiogr; 2010 Oct; 23(10):1025-34. PubMed ID: 20659788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 24. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study.
    Zoccali C; Benedetto FA; Tripepi G; Mallamaci F; Rapisarda F; Seminara G; Bonanno G; Malatino LS
    J Am Soc Nephrol; 2006 May; 17(5):1460-5. PubMed ID: 16597683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance: not all layers are the same.
    Xu L; Pagano JJ; Haykowksy MJ; Ezekowitz JA; Oudit GY; Mikami Y; Howarth A; White JA; Dyck JRB; Anderson T; Paterson DI; Thompson RB;
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):81. PubMed ID: 33267877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community.
    Whalley GA; Wright SP; Pearl A; Gamble GD; Walsh HJ; Richards M; Doughty RN
    Eur Heart J; 2008 Feb; 29(4):509-16. PubMed ID: 18276620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
    Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.
    Stoltze Gaborit F; Bosselmann H; Kistorp C; Iversen K; Kumler T; Gustafsson F; Goetze JP; Sölétormos G; Tønder N; Schou M
    BMC Cardiovasc Disord; 2016 May; 16():117. PubMed ID: 27246703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
    Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term outcome of patients with triphasic mitral flow with a mid-diastolic L wave: prognostic role of left atrial volume and N-terminal pro-brain natriuretic peptide.
    Kim SA; Son J; Shim CY; Choi EY; Ha JW
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1377-1384. PubMed ID: 28349264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure.
    Gaborit F; Bosselmann H; Tønder N; Iversen K; Kümler T; Kistorp C; Sölétormos G; Goetze JP; Schou M
    BMC Cardiovasc Disord; 2015 Aug; 15():92. PubMed ID: 26289429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.
    Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N;
    Int J Cardiol; 2018 Dec; 272():260-266. PubMed ID: 30144995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
    Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
    JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.